Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Therapeutic Advances in Pediatric Multiple Sclerosis.
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
Regulatory T cell number in multiple sclerosis patients: A meta-analysis.
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Including a subject-paced trial may make the PASAT more acceptable for MS patients.
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.
Impact of high intensity exercise on muscle morphology in EAE rats.
Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica.
Susceptibility genes are enriched in those of the HSV-1/host interactome in psychiatric and neurological disorders.
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
Analysis of CYP27B1 in multiple sclerosis.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Options in improving respiratory function in multiple sclerosis.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Recent advances and future challenges in the genetics of multiple sclerosis.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Role of glial 14-3-3 gamma protein in autoimmune demyelination.

Pages